Bioscience Summit Showcases Collaborations Among Industry and Education
“Collaboration” was the watchword of the 2024 BioScience Summit, held Sept. 17-18 in Fargo.
Drawing members of the industrial, higher education and entrepreneurial sectors, the conference sparked conversations and connections among the more than 300 attendees from 16 states, and Israel, Norway and Singapore.
Citing a worldwide biotechnology market of $1.3 trillion, Bioscience Association of North Dakota (BioND) executive director Richard Glynn said the time is right to capture more of those dollars in North Dakota—particularly with the state’s powerful incentive packages.
A biotech magnet on the Northern Plains
When BioND was established in 2010, the only substantial foothold biotechnology had in the region was Aldevron, Glynn said.
Founded in Fargo in 1998, Aldevron’s 2024 annual revenues exceeded $750 million. The company now exerts what North Dakota Commerce Commissioner Josh Teigen described as a “gravitational pull,” bringing in talent, capital and infrastructure.
Creating plasmid DNA, proteins, enzymes and other biologicals, Aldevron has spun off two additional companies, Genovac and Agathos Biologics, also based in Fargo.
Just five years ago, the Fargo-Moorhead MSA’s biotechnology sector was valued at $100 million in Gross Regional Product. Today, it’s at more than $300 million, said Joe Raso, President and CEO of the Greater Fargo Moorhead Economic Development Corporation.
The Red River Valley has momentum, and, as Teigen said, there is plenty of room to grow.
Click on the link below for the full story and check out the video.